Related Experiment Video
Updated: Jul 23, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Cervical Cancer Screening: Evolution of National Guidelines and Current Recommendations
1Department of Obstetrics and Gynecology, Stanford University School of Medicine, Redwood City, California.
Abstract:
Cancer of the cervix is preventable through vaccination against human papillomavirus and by screening and treatment of cervical precancers. Cervical cancer screening has evolved since the Pap smear was first discovered in the 1920s. Current guidelines from the US Preventive Services Task Force and the American Cancer Society incorporate the use of cervical cytology and high-risk human papillomavirus tests performed every 3 to 5 years for screening in average-risk asymptomatic patients. Testing should begin at age 21 to 25 years old and stop at 65 years old if sufficient cessation criteria has been met.
More Related Videos
Related Concept Videos
Preventive Healthcare Services
Cancer Prevention
Some...
Standards of Care II
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Current Trends in Nursing II
Standards of Care I

